Goldman Sachs Sticks to Their Sell Rating for Clorox (CLX)
Goldman Sachs analyst Bonnie Herzog maintained a Sell rating on Clorox yesterday. The company’s shares closed yesterday at $105.67.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Herzog covers the Consumer Defensive sector, focusing on stocks such as Philip Morris, Church & Dwight, and Constellation Brands. According to TipRanks, Herzog has an average return of 5.2% and a 55.75% success rate on recommended stocks.
Currently, the analyst consensus on Clorox is a Hold with an average price target of $115.33.
Based on Clorox’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.67 billion and a net profit of $157 million. In comparison, last year the company earned a revenue of $1.69 billion and had a net profit of $193 million
Read More on CLX:
Disclaimer & DisclosureReport an Issue
- Clorox price target lowered to $110 from $125 at Wells Fargo
- Clorox price target lowered to $110 from $121 at UBS
- Balanced Risk-Reward on Clorox: Limited Near-Term Upside Despite GOJO-Driven Revenue Boost and ERP-Inflated Growth Comparisons
- Clorox Completes Acquisition of Purell Maker GOJO Industries
- Clorox completes acquisition of Gojo Industries
